Condition
Chromosome Disorders
Total Trials
5
Recruiting
1
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Unknown1
Recruiting1
Terminated1
Completed1
Not Yet Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07807540Not Yet Recruiting
Hematological Profile in Children With Numerical Chromosomal Disorders
NCT07625579Recruiting
Collaboration for Down Syndrome Progress (CDP)
NCT05657860Phase 4Completed
Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
NCT00691574Not ApplicableTerminatedPrimary
Melatonin Levels in Smith Magenis Syndrome (SMS)
NCT00064597UnknownPrimary
Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood
Showing all 5 trials